Skip to main content

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Investor Investigation In Connection With Executive Compensation Announced

  • If you are a current long-term stockholder of shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Jan. 25, 2013 (Shareholders Foundation) -- An investigation on behalf of current long term investors in shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) was announced concerning whether certain officers and directors of Anthera Pharmaceuticals Inc breached their fiduciary duties by paying certain top officials at Anthera Pharmaceuticals excessive compensation. The investigation by ...



You must register (for free) or login to view the entire investigation.